Note: Ingredients listed on restricted chemical lists
EC/CAS
1310-73-2
Name of the chemical
sodium hydroxide
Concentration
N/A
EC/CAS
7647-01-0
Name of the chemical
Hydrochloric acid
Concentration
N/A
General Information
Revision date
2026-01-27
Product name
Plerixafor Injection 24mg/1.2mL(20mg/mL)
Manufacturer Name
Hetero Labs Limited
Icons in SDS
Company Information
company name
Camber Pharmaceuticals, Inc.
GHS Information
Signal word
Warning
Section 2
SECTION 2: Hazards identification
Hazard statements
H361- Suspected of damaging fertility or the unborn child.
Precautionary statements
P201- Obtain special instructions before use P202-. Do not handle until all safety precautions have been read and understood .P280- Wear protective gloves, protective clothing, eye protection. P308+P313- If exposed or concerned. Get medical advice/attention. P405- Store locked up. P501- Dispose of contents/container in accordance with local, regional, national, territorial, provincial, and international regulations.
2.3 Other hazards
Exposure may aggravate pre-existing eye, skin, or respiratory conditions Unknown acute toxicity (GHS Not applicable US/CA)
